Hasil Pencarian - Gabriel Tinoco

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor

    First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor oleh Rebecca Ganzon, Wei Chen, Gabriel Tinoco

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Schnitzler’s Syndrome: A Case Report

    Schnitzler’s Syndrome: A Case Report oleh Gabriel Tinoco, Rehan Kanji, Deepthi Moola

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma

    Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma oleh Maximilian Brockwell, Marium Husain, Claire Verschraegen, Richard Wu, Gabriel Tinoco

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Treating Breast Cancer in the 21st Century: Emerging Biological Therapies

    Treating Breast Cancer in the 21st Century: Emerging Biological Therapies oleh Gabriel Tinoco, Sean Warsch, Stefan Glück, Kiran Avancha, Alberto J. Montero

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager

    372 Single-agent anti-tumor activity in relapsed/refractory solid tumors: interim data from the phase 1 solid tumor trial of AMV564, a novel T-cell engager oleh Victoria Smith, Patrick Chun, Alexander Starodub, Sarina Piha-Paul, Raghad Karim, Michael Shafique, Gabriel Tinoco Suarez, Curtis Ruegg

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinical markers of immunotherapy outcomes in advanced sarcoma

    Clinical markers of immunotherapy outcomes in advanced sarcoma oleh Marium Husain, Dionisia Quiroga, Han Gil Kim, Scott Lenobel, Menglin Xu, Hans Iwenofu, James L. Chen, Claire Verschraegen, David Liebner, Gabriel Tinoco

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.

    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cell... oleh Luyuan Li, Ana C Paz, Breelyn A Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C Trent

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis

    Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis oleh Dionisia Quiroga, David A. Liebner, Jennifer S. Philippon, Sarah Hoffman, Yubo Tan, James L. Chen, Scott Lenobel, Paul E. Wakely, Raphael Pollock, Gabriel Tinoco

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Is digital mammography reducing radiation doses to women?

    Is digital mammography reducing radiation doses to women? oleh Marilice Valverde, João Peixoto, Eduardo de Paiva, Leonardo Travassos, Gabriel Tinoco, Paul Oliveira, Michel Passos, Sonia Silva, Flávia Aduan, Josilene Santos, Alex Campos, Anna Araújo

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

    Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications oleh Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, Marium Husain, James S. Bassett, Lei Wang, Gabriel Tinoco, Sandip H. Patel, Jarred Burkart, Abdul Miah, Mingjia Li, Andrew Johns, Madison Grogan, David P. Carbone, Claire F. Verschraegen, Kari L. Kendra, Gregory A. Otterson, Lang Li, Carolyn J. Presley, Dwight H. Owen

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: